EUSA Pharma (Denmark) ApS — Credit Rating and Financial Key Figures

CVR number: 39055988
Rygårds Allé 104, 2900 Hellerup

Income statement (kDKK)

2019
2020
2021
2022
2023
Fiscal period length1212121212
Net sales
Gross profit2 058.009 830.009 429.003 038.001 928.89
Employee benefit expenses-1 773.00-8 946.00-8 782.00-2 779.00-1 822.88
EBIT285.00884.00647.00259.00106.00
Other financial income2.0029.0089.28
Other financial expenses-9.00- 105.00-28.00-62.00-13.93
Pre-tax profit276.00779.00621.00226.00181.36
Income taxes-48.00- 172.00- 139.00-27.00-40.35
Net earnings228.00607.00482.00199.00141.01

Assets (kDKK)

2019
2020
2021
2022
2023
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current trade debtors33.00
Current amounts owed by group member comp.572.001 504.001 018.001 331.00408.02
Current other receivables1.00718.00350.0068.00161.59
Current deferred tax assets15.97
Short term receivables total573.002 222.001 401.001 399.00585.57
Cash and bank deposits316.00735.00332.00615.001 452.96
Cash and cash equivalents316.00735.00332.00615.001 452.96
Balance sheet total (assets)889.002 957.001 733.002 014.002 038.54

Equity and liabilities (kDKK)

2019
2020
2021
2022
2023
Share capital50.0050.0050.0050.0050.00
Retained earnings-63.00165.00773.001 255.001 453.73
Profit of the financial year228.00607.00482.00199.00141.01
Shareholders equity total215.00822.001 305.001 504.001 644.74
Non-current liabilities total
Current trade creditors208.00
Short-term deferred tax liabilities48.00172.00127.00
Other non-interest bearing current liabilities626.001 963.00301.00302.00393.80
Current liabilities total674.002 135.00428.00510.00393.80
Balance sheet total (liabilities)889.002 957.001 733.002 014.002 038.54
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.